// App-Quantinova.ai

[THU0088] : SERUM SURVIVIN PREDICTS TREATMENT RESPONSE IN ACTIVE RHEUMATOID ARTHRITIS

Researchers

Presenter

  • A. Levitsky

Principal Investigators

  • M. Erlandsson

  • R.F. van Vollenhoven

  • M.I. Bokarewa

Medical Centers

  • Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska University Hospital, University of Gothenburg, Gothenburg, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Sulfasalazine

  • Methotrexate

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved